DRI detector delivers outstanding GPC/SEC results Kumar Jeetendra | January 5, 2023 Operating from room temperature up to 80° C, with high thermal stability, the TESTA Analytical Differential Refractive Index (DRI) detector offers highly accurate and reliable determination of absolute concentration and total mass balance in GPC/SEC applications. DRI detectors are the most commonly used GPC/SEC detectors because of their universal applicability; they do not require chromophores …
Alembic Pharmaceuticals’ Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg, gain USFDA approval. Kumar Jeetendra | January 6, 2023 06th January 2023, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Toviaz Extended-Release …
Sirio Pharma Successfully Completes the Acquisition of Best Formulations Kumar Jeetendra | January 9, 2023 January 9, 2023 – City of Industry, CA — Sirio Pharma Co., Ltd. (Sirio), a leading global CDMO, today announced that it has completed the acquisition of a majority stake in Best Formulations LLC, a leading contract manufacturer of Nutritional Supplements and Personal Care products based in California. With more than 35 years of experience, …
Environics EnviroGlobe reduces electromagnetic radiation and enhances sleep by 8.3%: AIIMS Study Kumar Jeetendra | January 16, 2023 Environics is proud to announce the results of a research study conducted with both AIIMS and Apollo Hospitals on the efficacy of Enviroglobe. The study found that the use of Enviroglobe resulted in reducing the interference of EMR with the cellular communication of the body and resulted in a statistically significant improvement in sleep efficiency, …
Alembic Pharmaceuticals gets USFDA tentative approval for 100 mg Acalabrutinib capsules. Kumar Jeetendra | January 20, 2023 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA), Acalabrutinib Capsules, 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Calquence Capsules, 100 mg, of AstraZeneca UK Limited (AstraZeneca). Acalabrutinib Capsules are …
CIPLA launches CIPPOINT, a point-of-care gadget for non-communicable, infectious, and other disorders. Kumar Jeetendra | January 20, 2023 Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced the launch of Cippoint, a point-of-care testing device. This state-of-the-art device offers a wide range of testing parameters including cardiac markers, diabetes, infectious diseases, fertility, thyroid function, inflammation, metabolic markers, and coagulation markers. The device is CE IVD approved – …
GenNext Technologies Appoints Dr. Lisa Jones of UCSD to the Role of Chief Science Officer (CSO) Kumar Jeetendra | January 20, 2023 With ambitious plans to expand the reach and impact of their Flash Oxidation (Fox™) Protein Footprinting System beyond in vitro proteins, GenNext Technologies, Inc. (GenNext) is adding to the strength of their leadership team with the selection of Dr. Lisa Jones as the company’s new CSO. Transitioning from her role on the company’s Scientific Advisory …
Sun Pharma has agreed to pay $576 million for the acquisition of the US-based Concert. Kumar Jeetendra | January 20, 2023 Sun Pharmaceutical Industries Limited announced on Thursday that it would purchase Concert Pharmaceuticals of the United States for $576 million in cash in order to gain access to an investigational medication for the treatment of patchy baldness. Deuruxolitinib, the top contender for Concert, is being studied as a treatment for the autoimmune disorder alopecia areata, …
The founder of Bharat Biotech advocates for incentives, tax advantages, and innovation Kumar Jeetendra | January 21, 2023 Dr. Krishna Ella, the founder of Bharat Biotech, advocated on Friday for “research connected incentives” and tax breaks for new goods based on ground-breaking and patented invention carried out within the nation. “Research linked incentive for Indian companies is very important. I would request the ministry to give tax breaks to any product that is …
Cloud Based Smart Chemistry Platform Kumar Jeetendra | January 23, 2023 Asynt reports on the cloud-based SmartChemistry® platform to share chemical reaction and sensor data direct from the laboratory to allowing analysis of this information on an unprecedented scale. Developed by the deepmatter Group (https://www.deepmatter.io/), this unique platform allows reaction data to be compiled from multiple data sources to provide a cleansed, harmonised, and categorised repository for the exploitation of …
Oncquest marks its 21st anniversary by introducing a world-class Cytogenetic Workstation Kumar Jeetendra | January 24, 2023 Carrying forward its legacy of advancing the country’s diagnostic services, Oncquest Laboratories Ltd, on the completion of 21 years, has introduced a world-class facility for Cytogenetic Analysis in association with World Leaders in Microscopy and Imaging Systems – Carl Zeiss and MetaSystems, Germany. The fully automated Cytogenetics Workstation is a rare facility that only a …
Husky demonstrates strengthened commitment to enabling regional producers at Plastindia 2023 Kumar Jeetendra | February 1, 2023 BOLTON, Ontario – Husky TechnologiesTM, a pioneering technology provider enabling the delivery of essential needs to the global community, today announced its return to exhibit at Plastindia 2023 (February 1-5, New Delhi, India). At the show, Husky is featuring how its versatile range of technologies,solutions and services enable India’s food and beverage packaging, consumer goods …
